Professor Paul Clarke

BSc(Hons), PhD, FRSB

Director, Frazer Institute

Research Themes

Cancer and Blood Diseases

My Research

Control of the cell cycle and cell death in cancer


Control of mitotic cell death by tumor suppressors and oncogenes

Cellular responses to cancer chemotherapeutic drugs

Control of mitosis and chromosomal instability

About me

Paul Clarke is Director of the Frazer Institute, a leading translational medical research centre studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease. Professor Clarke became Director in 2017 and was previously Associate Dean (Research) in Medicine at the University of Dundee in Scotland, Senior Research Fellow at the University of Manchester in England, and Research Fellow at the European Molecular Biology Laboratory in Heidelberg, Germany. Professor Clarke studied Biochemstry at the University of Bristol and undertook research for his PhD at the University of Dundee. 

Frazer Institute, formerly UQ Diamantina Institute, is named in honour of its Founding Director, Emeritus Professor Ian Frazer, co-discoverer of the Gardasil HPV cervical cancer vaccine. Frazer Institute is part of The University of Queensland Faculty of Medicine and is a key partner in the Translational Research Institute, a $360 research facility at the Princess Alexandra Hospital precinct in Woolloongabba. Scientists and clinical researchers at Frazer Institute develop new methods for the prevention, detection and treatment of human diseases.